NCT03303846View on ClinicalTrials.gov

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

April 25, 2026

Study Completion Date

April 25, 2026

Conditions
Healthy Subject
Interventions
PROCEDURE

Magnetic Resonance Imaging

Undergo high risk breast cancer screening MRI

PROCEDURE

Biospecimen Collection

Undergo blood and tissue sample collection

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (5)

27705

Duke University, Durham

43212

Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus

90033

University of Southern California, Los Angeles

91010

City of Hope Medical Center, Duarte

537192

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT03303846 - Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients | Biotech Hunter | Biotech Hunter